| Product Code: ETC8548567 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Short Bowel Syndrome Drugs Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Short Bowel Syndrome Drugs Market - Industry Life Cycle |
3.4 Netherlands Short Bowel Syndrome Drugs Market - Porter's Five Forces |
3.5 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Short Bowel Syndrome Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of short bowel syndrome in the Netherlands |
4.2.2 Growing awareness about treatment options for short bowel syndrome |
4.2.3 Advances in pharmaceutical research leading to the development of innovative drugs for the condition |
4.3 Market Restraints |
4.3.1 High cost associated with short bowel syndrome drugs |
4.3.2 Limited availability of specialized healthcare facilities for managing short bowel syndrome patients in the Netherlands |
5 Netherlands Short Bowel Syndrome Drugs Market Trends |
6 Netherlands Short Bowel Syndrome Drugs Market, By Types |
6.1 Netherlands Short Bowel Syndrome Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Glucagon-like Peptide, 2021- 2031F |
6.1.4 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Anti-Diarrheal, 2021- 2031F |
6.1.5 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Histamine Blockers, 2021- 2031F |
6.1.6 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Proton Pump Inhibitors, 2021- 2031F |
6.1.7 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Growth Hormone, 2021- 2031F |
6.1.8 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Short Bowel Syndrome Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Short Bowel Syndrome Drugs Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Short Bowel Syndrome Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Netherlands Short Bowel Syndrome Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Netherlands Short Bowel Syndrome Drugs Market Import-Export Trade Statistics |
7.1 Netherlands Short Bowel Syndrome Drugs Market Export to Major Countries |
7.2 Netherlands Short Bowel Syndrome Drugs Market Imports from Major Countries |
8 Netherlands Short Bowel Syndrome Drugs Market Key Performance Indicators |
8.1 Patient adherence to prescribed treatment regimens |
8.2 Number of clinical trials and research studies focused on short bowel syndrome drugs in the Netherlands |
8.3 Rate of adoption of new short bowel syndrome drugs in the market |
9 Netherlands Short Bowel Syndrome Drugs Market - Opportunity Assessment |
9.1 Netherlands Short Bowel Syndrome Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Short Bowel Syndrome Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Short Bowel Syndrome Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Netherlands Short Bowel Syndrome Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Short Bowel Syndrome Drugs Market - Competitive Landscape |
10.1 Netherlands Short Bowel Syndrome Drugs Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Short Bowel Syndrome Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here